Please ensure Javascript is enabled for purposes of website accessibility
People Who Got COVID Before Will be Exposed Again for Human Challenge Study
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 4 years ago on
April 19, 2021

Share

Researchers at the University of Oxford have launched a human challenge trial to look at what kind of immune response can stop people from becoming re-infected from COVID-19. They also want to see how the immune system reacts second time round.

A human challenge trial in medical research is a carefully controlled study that involves purposefully infecting a subject with a pathogen or bug, in order to study the effects of that infection.

Two Phases

The study will take place in two phases with different participants in each phase. The first phase, which will start in April 2021, will establish the lowest dose of virus which, in approximately 50% of people who have previously been naturally infected, can take hold and start replicating but produce little or no symptoms. In the second phase of the study, expected to start in summer 2021, all participants will be infected with the standardized dose of virus which was established in phase one.

For phase one, up to 64 healthy participants between the ages of 18 – 30 who have previously been naturally infected with COVID-19 will be re-exposed to the virus in carefully controlled conditions.

The virus used in the study will be the original strain from Wuhan, China.

The participants will be quarantined in a specially designed hospital suite for a minimum of 17 days under the care of the research team.

They will undergo numerous medical tests including CT scans of the lungs and MRI scans of the heart. The risks to participants will minimized by making sure that those who take part are completely fit and well and have completely recovered from their first infection with COVID.

If Anyone Develops Symptoms

Any participants who develop any symptoms will be given medical treatment with the Regeneron monoclonal antibody treatment.

They will only be discharged from the quarantine unit when they are no longer infected and not at risk of infecting others. The full length of the study will be 12 months, including a minimum of eight follow-up appointments after discharge. Participation in the study is completely voluntary.

Tightly Controlled

Helen McShane, Professor of Vaccinology at the Department of Pediatrics, University of Oxford and Chief Investigator on the study said, “Challenge studies tell us things that other studies cannot because, unlike natural infection, they are tightly controlled.”

The study is funded by the Wellcome Trust.

“When we re-infect these participants, we will know exactly how their immune system has reacted to the first COVID infection, exactly when the second infection occurs, and exactly how much virus they got,” said McShane. “As well as enhancing our basic understanding, this may help us to design tests that can accurately predict whether people are protected.”

Future Implications

“The findings could have important implications for how we handle COVID-19 in the future,” said McShane. “Keeping up the pace of scientific research and development, through crucial studies such as this remain the only way we will truly get ahead of this pandemic and bring it under control.”

DON'T MISS

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

DON'T MISS

GOP Picks up Key House Seats While Democrats Say They Still Have a Path to a Majority

DON'T MISS

Costa Expands Lead Over Maher, Richardson Holds Narrow Edge on Bonakdar

DON'T MISS

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

DON'T MISS

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

DON'T MISS

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

DON'T MISS

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

DON'T MISS

President-Elect Trump Names Susie Wiles as Chief of Staff

DON'T MISS

Robert F. Kennedy Jr., Foe of Drugmakers and Regulators, Is Poised to Wield New Power

DON'T MISS

California Beat Trump in Court His First Term. It’s Preparing New Cases for His Second.

UP NEXT

Large Airstrikes Hit Beirut Suburbs as Israel Expands Northern Gaza Operations

UP NEXT

Putin Congratulates Trump on His Election Victory in His First Public Comments on the US Vote

UP NEXT

8-Hour Russian Drone Barrage Keeps Kyiv on Edge as War in Ukraine Nears 1,000 Days

UP NEXT

Cuba Left Reeling After Category 3 Hurricane Ravages Island and Knocks Out Power Grid

UP NEXT

Trump Promises to Bring Lasting Peace to a Tumultuous Middle East. But Fixing It Won’t Be Easy

UP NEXT

Lebanon Files Complaint Against Israel at UN Labor Body Over Deadly Pager Explosions

UP NEXT

Despite Trump’s Unpredictability, Netanyahu Sees a More Favorable US President

UP NEXT

Israeli Strikes Target Syria for a Second Day in a Row

UP NEXT

Israel’s Netanyahu Dismisses Defense Minister in Surprise Announcement

UP NEXT

Palestinians in Gaza Fear Neither Candidate in US Election Will Help Them

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

3 hours ago

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

4 hours ago

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

4 hours ago

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

4 hours ago

President-Elect Trump Names Susie Wiles as Chief of Staff

5 hours ago

Robert F. Kennedy Jr., Foe of Drugmakers and Regulators, Is Poised to Wield New Power

5 hours ago

California Beat Trump in Court His First Term. It’s Preparing New Cases for His Second.

6 hours ago

With Mountain West Title Out of Reach, What Is Fresno State Playing For?

7 hours ago

Former Fresno State Bull Rider, a Vietnam Vet, Calls Central Valley Honor Flight ‘Life-Changing’

7 hours ago

Don’t Expect Kamala Harris’ Loss to Boost Gavin Newsom’s Presidential Prospects

7 hours ago

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

The city of Fresno now owns a new park. Or at least half of it. Technically, the city of Fresno did not own El Dorado Park, at Barstow Avenu...

2 hours ago

2 hours ago

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

The U.S. Capitol is seen from Pennsylvania Avenue in Washington, on Election Day, Tuesday, Nov. 5, 2024. (AP Photo/Jon Elswick)
3 hours ago

GOP Picks up Key House Seats While Democrats Say They Still Have a Path to a Majority

3 hours ago

Costa Expands Lead Over Maher, Richardson Holds Narrow Edge on Bonakdar

3 hours ago

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

4 hours ago

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

4 hours ago

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

4 hours ago

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

Trump co-campaign manager Susie Wiles is seen at Nashville International Airport as Republican presidential candidate former President Donald Trump arrives, July 27, 2024, in Nashville, Tenn. (AP File)
5 hours ago

President-Elect Trump Names Susie Wiles as Chief of Staff

Search

Send this to a friend